{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:35:08Z","timestamp":1793367308644,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejso.2026.112058","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T23:28:34Z","timestamp":1786663714000},"page":"112058","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Re-cytoreduction predictive Index(RECPI)-based Immune-Ascites(IMA) scoring system for peritoneal metastatic disease: A paired-analysis of surgical and oncological outcomes"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4755-2200","authenticated-orcid":false,"given":"Berke","family":"Mano\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8235-7246","authenticated-orcid":false,"given":"Selman","family":"S\u00f6kmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7040-4228","authenticated-orcid":false,"given":"Tayfun","family":"Bi\u015fgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3731-2978","authenticated-orcid":false,"given":"Ay\u015fe Co\u015fkun","family":"Beyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beste","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8503-061X","authenticated-orcid":false,"given":"H\u00fclya","family":"Ellidokuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2026.112058_bib1","first-page":"164","article-title":"Intra-peritoneal chemo-hyperthermia (CHIP): a new therapy in the treatment of the peritoneal seedings Preliminary report","volume":"76","author":"Gilly","year":"1991","journal-title":"Int Surg"},{"key":"10.1016\/j.ejso.2026.112058_bib2","series-title":"Technical handbook for the integration of cytoreductive surgery and perioperative intraperitoneal chemotherapy into the surgical management of gastrointestinal and gynecologic malignancy","author":"Sugarbaker","year":"2005"},{"key":"10.1016\/j.ejso.2026.112058_bib3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1470-2045(04)01425-1","article-title":"Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia","volume":"5","author":"Glehen","year":"2004","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2026.112058_bib4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-1-4613-1245-1_13","article-title":"Peritoneal carcinomatosis: natural history and rational therapeutic interventions using intraperitoneal chemotherapy","volume":"81","author":"Sugarbaker","year":"1996","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.ejso.2026.112058_bib5","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1245\/s10434-010-1039-7","article-title":"Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy","volume":"17","author":"Glehen","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.112058_bib6","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1245\/s10434-006-9182-x","article-title":"A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei","volume":"14","author":"Yan","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.112058_bib7","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1200\/JCO.2004.10.012","article-title":"Cytoreductive surgery combined with peritoperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multiinstitutional study","volume":"22","author":"Glehen","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2026.112058_bib8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/cncr.23553","article-title":"Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer","volume":"113","author":"Giorgio","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2026.112058_bib9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/ijgc-00009577-200601000-00004","article-title":"Primary peritoneal carcinoma: experience with cytoreductive surgery and combination chemotherapy","volume":"16","author":"Nam","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejso.2026.112058_bib10","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","article-title":"Cytoreducive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience","volume":"27","author":"Yan","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2026.112058_bib11","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/bjs.6235","article-title":"Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"95","author":"Elias","year":"2008","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2026.112058_bib12","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","article-title":"Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Chua","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2026.112058_bib13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1245\/s10434-007-9678-z","article-title":"Survival and health outcomes after cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of appendiceal origin","volume":"15","author":"McQuellon","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.112058_bib14","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jamcollsurg.2009.04.019","article-title":"Complete cytoreduction offers longterm survival in patients with paritoneal carcinomatosis from appendiceal tumors of unfavorable histology","volume":"209","author":"Omohwo","year":"2009","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.ejso.2026.112058_bib15","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","article-title":"Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin","volume":"27","author":"Elias","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2026.112058_bib16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejso.2010.10.014","article-title":"Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: italian multicenter study S.I.T.I.L.O","volume":"37","author":"Cavaliere","year":"2011","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2026.112058_bib17","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.amjsurg.2011.02.004","article-title":"Outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface dissemination from ovarian neoplasms","volume":"202","author":"Parson","year":"2011","journal-title":"Am J Surg"},{"key":"10.1016\/j.ejso.2026.112058_bib18","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/jso.21682","article-title":"Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer","volume":"102","author":"Roviello","year":"2010","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejso.2026.112058_bib19","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/annonc\/mdl428","article-title":"A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma","volume":"18","author":"Yan","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2026.112058_bib20","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0399-8320(07)73964-7","article-title":"Malignant peritoneal mesothelioma: treatment with maximal cytoreductive surgery plus intraperitoneal chemotherapy","volume":"31","author":"Elias","year":"2007","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.ejso.2026.112058_bib21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1245\/ASO.2004.08.014","article-title":"Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: location, treatment, and outcome","volume":"11","author":"Verwaal","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.112058_bib22","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1245\/s10434-009-0611-5","article-title":"The second procedure combining complete cytoreductive surgery and intraperitoneal chemotherapy for isolated peritoneal recurrence: postoperative course and long-term outcome","volume":"16","author":"Brouquet","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.112058_bib23","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/01.sla.0000231705.40081.1a","article-title":"Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"245","author":"Smeenk","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2026.112058_bib24","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1245\/s10434-007-9462-0","article-title":"Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms","volume":"14","author":"Yan","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.112058_bib25","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jamcollsurg.2012.04.023","article-title":"Outcomes of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy","volume":"215","author":"Votanopoulos","year":"2012","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.ejso.2026.112058_bib26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1245\/ASO.2006.03.045","article-title":"Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion","volume":"13","author":"Deraco","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.112058_bib27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-1-4613-1245-1_6","article-title":"Surgically directed chemotherapy: heated intraperitoneal lavage with mitomycin C","volume":"81","author":"Fernandez\u2010Trigo","year":"1996","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.ejso.2026.112058_bib28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1200\/JCO.2011.37.1039","article-title":"Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841","volume":"30","author":"Franko","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2026.112058_bib29","first-page":"169","article-title":"Emergency abdominal re-exploration in a district general hospital","volume":"69","author":"Wain","year":"1987","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1016\/j.ejso.2026.112058_bib30","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1016\/S1470-2045(14)70263-3","article-title":"Cancer-related inflammation and treatment effectiveness","volume":"15","author":"Diakos","year":"2014","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2026.112058_bib31","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ctrv.2012.08.003","article-title":"The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer","volume":"39","author":"McMillan","year":"2013","journal-title":"Cancer Treat Rev"},{"issue":"12","key":"10.1016\/j.ejso.2026.112058_bib32","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1002\/cncr.28018","article-title":"Optimization of the systemic inflammation-based Glasgow prognostic score: a Glasgow Inflammation Outcome Study","volume":"119","author":"Proctor","year":"2013","journal-title":"Cancer"},{"issue":"10135","key":"10.1016\/j.ejso.2026.112058_bib33","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","article-title":"International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study","volume":"391","author":"Pag\u00e8s","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2026.112058_bib34","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1007\/s00432-014-1692-5","article-title":"Different sequential approaches of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treating ovarian cancer with malignant ascites","volume":"140","author":"Ba","year":"2014","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ejso.2026.112058_bib35","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1245\/s10434-013-3224-y","article-title":"Efficacy of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in the management of malignant ascites","volume":"21","author":"Randle","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.112058_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-68639-2","article-title":"Ascites-induced compression alters the peritoneal microenvironment and promotes metastatic success in ovarian cancer","volume":"10","author":"Asem","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejso.2026.112058_bib37","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1007\/s00464-013-2800-3","article-title":"Multivariate comparison of B-ultrasound guided and laparoscopic continuous circulatory hyperthermic intraperitoneal perfusion chemotherapy for malignant ascites","volume":"27","author":"Ba","year":"2013","journal-title":"Surg Endosc"},{"key":"10.1016\/j.ejso.2026.112058_bib38","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3892\/or.2012.1913","article-title":"B ultrasound-guided hyperthermic intraperitoneal perfusion chemotherapy for the treatment of malignant ascites","volume":"28","author":"Cui","year":"2012","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ejso.2026.112058_bib39","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.3748\/wjg.v16.i15.1901","article-title":"Chemotherapy with laparoscope-assisted continuous circulatory hyperthermic intraperitoneal perfusion for malignant ascites","volume":"16","author":"Ba","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejso.2026.112058_bib40","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/01.sla.0000255561.87771.11","article-title":"Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases","volume":"245","author":"Kianmanesh","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2026.112058_bib41","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/jso.23062","article-title":"Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results","volume":"106","author":"Golse","year":"2012","journal-title":"J Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2026.112058_bib42","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3390\/cancers15030607","article-title":"Repeated cytoreduction combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in selected patients affected by peritoneal metastases: italian PSM oncoteam evidence","volume":"15","author":"Pasqual","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.ejso.2026.112058_bib43","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.surge.2019.11.005","article-title":"Re-do cytoreductive surgery for peritoneal surface malignancy: is it worthwhile?","volume":"18","author":"Narasimhan","year":"2020","journal-title":"Surgeon"},{"key":"10.1016\/j.ejso.2026.112058_bib44","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/jso.24703","article-title":"Interval between cytoreductions as a marker of tumor biology in selecting patients for repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","volume":"116","author":"Konstantinidis","year":"2017","journal-title":"J Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2026.112058_bib45","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/jso.25277","article-title":"Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: a multi-institutional experience","volume":"119","author":"Alzahrani","year":"2019","journal-title":"J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2026.112058_bib46","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s10147-017-1217-8","article-title":"Repeat cytoreduction and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal carcinomatosis of appendiceal origin","volume":"23","author":"Kitai","year":"2018","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ejso.2026.112058_bib47","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1200\/JCO.2008.19.6147","article-title":"In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer","volume":"27","author":"Pages","year":"2009","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.112058_bib48","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41416-018-0095-9","article-title":"The prognostic value of systemic inflammation in patients undergoing surgery for colon cancer: comparison of composite ratios and cumulative scores","volume":"119","author":"Dolan","year":"2018","journal-title":"Br J Cancer"},{"issue":"7","key":"10.1016\/j.ejso.2026.112058_bib49","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/bjc.2013.508","article-title":"Detailed analysis of inflammatory cell infiltration in colorectal cancer","volume":"109","author":"V\u00e4yrynen","year":"2013","journal-title":"Br J Cancer"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326006773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326006773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:46:36Z","timestamp":1793364396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326006773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0748798326006773"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.112058","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Re-cytoreduction predictive Index(RECPI)-based Immune-Ascites(IMA) scoring system for peritoneal metastatic disease: A paired-analysis of surgical and oncological outcomes","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.112058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112058"}}